Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pentetrazol

EU orphan designation number: EU/3/15/1569   
Active ingredient: Pentetrazol
Indication: Treatment of idiopathic hypersomnia
Sponsor: Balance Therapeutics, Limited
5 New Street Square, London EC4A 3TW, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/11/2015 Orphan designation EMA/OD/097/15 (2015)8019 of 11/11/2015
19/01/2016 Transfer of orphan designation EMA/OD/097/15/T/01 (2016)257 of 15/01/2016